Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism.

Res Pract Thromb Haemost · 2018 · PMC6055557 · PMID 30046707

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significanceP = .11not close (p > 0.1)

17 A marginal increase in the rate of major bleeding that did not reach statistical significance was observed in the rivaroxaban cohort (0.7% vs 0% for placebo; P = .11).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.